Clinical Trials Directory

Trials / Unknown

UnknownNCT02804100

Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients

A Multi-centre Observational Study on Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients Under Gefitinib Treatment

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Wenzhou Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A multi-centre observational, non-interventional study is to dynamically monitor the changes of circulating tumor DNA (ctDNA) in late stage NSCLC patients under Gefitinib treatment.

Conditions

Timeline

Start date
2016-05-01
Primary completion
2017-12-01
Completion
2018-06-01
First posted
2016-06-17
Last updated
2016-11-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02804100. Inclusion in this directory is not an endorsement.